News By Topic
Genentech, Inc.
Genentech the ventriloquist
Yesterday, we talked about Genentech in the early years. Today we look at an example of what they have become. Nor are they alone; I chose Genentech ...
Genentech, Biogen get FDA request on Rituxan
Genentech Inc. and partner Biogen Idec Inc. said Wednesday the Food and Drug Administration is withholding a decision to expand approval of Rituxan as ...
Lobbyists write health care reform speeches for Reps., including Lynn Jenkins
A not-so-shocking article from the New York Times reports 22 Republicans and 20 Democrats used eerily similar statements on health care reform from a ...
Lobbyists' influence and control in congress
Money talks. It always has. The New York Times reported today, November 15, that forty-two members of the American House of Representatives were ...
Curis shrinks 3Q loss as partnership revenue rises
Cancer drug developer Curis Inc. posted a narrower third-quarter loss Thursday due to greater revenue from partnerships. ...
Medicare reverses billing change on Genentech drug
Medicare officials are backing off a policy that pushed many doctors to use a $2,000 injectable drug for a potentially blinding eye disorder, over a ...
Los Angeles OKs plan to use Google Web services
City Council members tentatively approved a multimillion-dollar proposal Tuesday to tap Google Inc. for government e-mail and other Internet services, ...
|
Michael Marley
NY Boxing Examiner Most Recent Article Ambassador of ill will can stick Manny Pacquiao award where sun don't shine |